Literature DB >> 26758950

Roles of the Mevalonate Pathway and Cholesterol Trafficking in Pulmonary Host Defense.

Kristin A Gabor, Michael B Fessler1.   

Abstract

The mevalonic acid synthesis pathway, cholesterol, and lipoproteins play fundamental roles in lung physiology and the innate immune response. Recent literature investigating roles for cholesterol synthesis and trafficking in host defense against respiratory infection was critically reviewed. The innate immune response and the cholesterol biosynthesis/trafficking network regulate one another, with important implications for pathogen invasion and host defense in the lung. The activation of pathogen recognition receptors and downstream cellular host defense functions are critically sensitive to cellular cholesterol. Conversely, microorganisms can co-opt the sterol/lipoprotein network in order to facilitate replication and evade immunity. Emerging literature suggests the potential for harnessing these insights towards therapeutic development. Given that >50% of adults in the U.S. have serum cholesterol abnormalities and pneumonia remains a leading cause of death, the potential impact of cholesterol on pulmonary host defense is of tremendous public health significance and warrants further mechanistic and translational investigation. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cholesterol; innate immunity; lipoprotein; lung; pneumonia; statins.

Mesh:

Substances:

Year:  2017        PMID: 26758950      PMCID: PMC6026538          DOI: 10.2174/1874467209666160112123603

Source DB:  PubMed          Journal:  Curr Mol Pharmacol        ISSN: 1874-4672            Impact factor:   3.339


  228 in total

1.  Coordinate regulation of neutrophil homeostasis by liver X receptors in mice.

Authors:  Cynthia Hong; Yoko Kidani; Noelia A-Gonzalez; Tram Phung; Ayaka Ito; Xin Rong; Katrin Ericson; Hanna Mikkola; Simon W Beaven; Lloyd S Miller; Wen-Hai Shao; Philip L Cohen; Antonio Castrillo; Peter Tontonoz; Steven J Bensinger
Journal:  J Clin Invest       Date:  2011-12-12       Impact factor: 14.808

2.  Lovastatin enhances clearance of apoptotic cells (efferocytosis) with implications for chronic obstructive pulmonary disease.

Authors:  Konosuke Morimoto; William J Janssen; Michael B Fessler; Kathleen A McPhillips; Valeria M Borges; Russell P Bowler; Yi-Qun Xiao; Jennifer A Kench; Peter M Henson; R William Vandivier
Journal:  J Immunol       Date:  2006-06-15       Impact factor: 5.422

3.  Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans.

Authors:  P J Pentikainen; M Saraheimo; J I Schwartz; R D Amin; M S Schwartz; F Brunner-Ferber; J D Rogers
Journal:  J Clin Pharmacol       Date:  1992-02       Impact factor: 3.126

4.  Lipid rafts act as specialized domains for tetanus toxin binding and internalization into neurons.

Authors:  J Herreros; T Ng; G Schiavo
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

5.  Dyslipidemia induces opposing effects on intrapulmonary and extrapulmonary host defense through divergent TLR response phenotypes.

Authors:  Jennifer H Madenspacher; David W Draper; Kathleen A Smoak; Haitao Li; Gary L Griffiths; Benjamin T Suratt; Martha D Wilson; Lawrence L Rudel; Michael B Fessler
Journal:  J Immunol       Date:  2010-06-25       Impact factor: 5.422

6.  D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.

Authors:  Brian J Van Lenten; Alan C Wagner; Mohamad Navab; G M Anantharamaiah; Eric Ka-Wai Hui; Debi P Nayak; Alan M Fogelman
Journal:  Circulation       Date:  2004-11-08       Impact factor: 29.690

7.  Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial.

Authors:  J Montaner; P Chacón; J Krupinski; F Rubio; M Millán; C A Molina; P Hereu; M Quintana; J Alvarez-Sabín
Journal:  Eur J Neurol       Date:  2007-12-07       Impact factor: 6.089

8.  High-density lipoprotein reduces the human monocyte inflammatory response.

Authors:  Andrew J Murphy; Kevin J Woollard; Anh Hoang; Nigora Mukhamedova; Roslynn A Stirzaker; Sally P A McCormick; Alan T Remaley; Dmitri Sviridov; Jaye Chin-Dusting
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

9.  Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial.

Authors:  Laurent Papazian; Antoine Roch; Pierre-Emmanuel Charles; Christine Penot-Ragon; Gilles Perrin; Philippe Roulier; Philippe Goutorbe; Jean-Yves Lefrant; Sandrine Wiramus; Boris Jung; Sébastien Perbet; Romain Hernu; André Nau; Olivier Baldesi; Jerome Allardet-Servent; Karine Baumstarck; Elisabeth Jouve; Myriam Moussa; Sami Hraiech; Christophe Guervilly; Jean-Marie Forel
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

10.  Statins decrease lung inflammation in mice by upregulating tetraspanin CD9 in macrophages.

Authors:  Yingji Jin; Isao Tachibana; Yoshito Takeda; Ping He; Sujin Kang; Mayumi Suzuki; Hanako Kuhara; Satoshi Tetsumoto; Kazuyuki Tsujino; Toshiyuki Minami; Takeo Iwasaki; Kaori Nakanishi; Satoshi Kohmo; Haruhiko Hirata; Ryo Takahashi; Koji Inoue; Izumi Nagatomo; Hiroshi Kida; Takashi Kijima; Mari Ito; Hideyuki Saya; Atsushi Kumanogoh
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

View more
  5 in total

Review 1.  A New Frontier in Immunometabolism. Cholesterol in Lung Health and Disease.

Authors:  Michael B Fessler
Journal:  Ann Am Thorac Soc       Date:  2017-11

2.  Effects of rosuvastatin on the immune system in healthy volunteers with normal serum cholesterol.

Authors:  Peer Wf Karmaus; Min Shi; Shira Perl; Angélique Biancotto; Julián Candia; Foo Cheung; Yuri Kotliarov; Neal Young; Michael B Fessler
Journal:  JCI Insight       Date:  2019-11-01

3.  A Mathematical Model of In Vitro Cellular Uptake of Zoledronic Acid and Isopentenyl Pyrophosphate Accumulation.

Authors:  Elena Lo Presti; Laura D'Orsi; Andrea De Gaetano
Journal:  Pharmaceutics       Date:  2022-06-14       Impact factor: 6.525

Review 4.  Role for phospholipid acyl chains and cholesterol in pulmonary infections and inflammation.

Authors:  Saame Raza Shaikh; Michael B Fessler; Kymberly M Gowdy
Journal:  J Leukoc Biol       Date:  2016-06-10       Impact factor: 4.962

Review 5.  Regulation of ATP binding cassette transporter A1 (ABCA1) expression: cholesterol-dependent and - independent signaling pathways with relevance to inflammatory lung disease.

Authors:  Patrick He; Ingrid C Gelissen; Alaina J Ammit
Journal:  Respir Res       Date:  2020-09-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.